Please login to the form below
CNS
This page shows the latest CNS news and features for those working in and with pharma, biotech and healthcare.
Open Health merges with med comms services provider Peloton
The company says the deal allows it to better serve its US-based clients, along with boosting its science platform, thanks to Peloton’s expertise in rare disease, CNS, oncology and
Latest news
-
Redmile and Google help Evox raise £35.5m for exosome pipeline
Boehringer Ingelheim on an undisclosed RNA target and another, unnamed partner on using exosomes to deliver small-molecules for a CNS disease.
-
Daily Brief: Another next-gen diabetes research deal for Novo, Vertex and Australia break deadlock
The privately biotech is based in Philadelphia, PA with research laboratories in the UK specialises in develops novel biopharmaceuticals for a number of therapeutic areas including CNS which cross the Blood ... We look forward to developing a successful
-
Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland
As well as targeting the tumour in the lung, Alecensa also cuts the risk of tumours in the central nervous system (CNS), with the incidence of brain metastases high in this
-
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
The company unveiled its deal with AVV gene therapy specialists Lacerta yesterday, a $30 million equity investment in return for rights to license up to three new CNS-targeted gene therapy
-
Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member
The latest from pharma, biotech and healthcare. ‘Game changing CNS’ company Karuna raises $42m. ... Karuna has all of the characteristics we look for in a game-changing CNS company.
More from news
Approximately 4 fully matching, plus 155 partially matching documents found.
Latest Intelligence
-
Key considerations for disease- modifying Parkinson’s disease trials
By Dr Peter Schueler, Senior Vice President, Drug Development Services and Haichen Yang, Vice President, Global Therapeutic Lead, both at CNS, ICON plc.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
The company is working on RNAi molecules which can work in CNS, something which would expand its therapeutic possibilities enormously, and hopes to have its first CNS-targetting candidate enter clinical
-
A quest for innovative solutions
PRISM has matured into an artery of new opportunities such as its collaboration on RADAR-CNS (Remote Assessment of Disease and Relapse - Central Nervous System), an initiative that aims to develop
-
The good, the bad and the ugly
Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.
-
Pharma deals continue to slide
1, 410 (upfront 80). WuXi Biologics and Gloria Pharma (CN). Arcus Biosciences (US). ... 163. Mologen (DE). iPharma (CN). Binding term sheet for licensing and co-development.
More from intelligence
Approximately 0 fully matching, plus 40 partially matching documents found.
Latest appointments
-
Axovant poaches Allergan’s and Teva’s chief medical and science officers
development. “We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases.
-
Damien McDevitt moves from GSK to Acadia Pharmaceuticals
At Acadia, which focuses on the development and commercialisation of medicines for central nervous system (CNS) disorders, McDevitt will report to the company’s president and chief executive officer Steve Davis. ... This expertise, combined with his
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Menezes joins the group from Depomed Pharmaceuticals, where he served as vice president of sales and sales operations, pain and CNS.
-
emotive boosts its client services team
Joining as a senior account director, Andy Parry has 9 years’ experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.
-
Axon bolsters team with new PR Director hire
During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.
More from appointments
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest from PMHub
-
Shionogi Ltd. appoints Star for UK launch
Their pipeline focuses on infectious disease, pain, CNS and oncology. Star were chosen as preferred partner on the basis of the company’s ability to provide the very best talent to
-
A fast-growing client services team at emotive.
Starting his career in Medical Education and then moving into healthcare advertising, Andy has worked on large global brands in CNS, infectious diseases, respiratory and rare diseases. ... Also with a Biomedical Science degree, Sabrina worked in
-
M3 announces further expansion into Europe and Latin America with the acquisition of Vidal Group
About M3:. M3 operates in Asia, the US and Europe with more than 4 million physician doctor members globally via M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk.
-
New appointments announced across Research Partnership’s global offices
Marianne has over 15 years’ experience in healthcare marketing research. She has extensive experience in a variety of therapy areas including oncology, diabetes, autoimmune disorders, CNS, women’s health and cardiovascular
-
Sanofi on lack of customer understanding
We need to understand customer value and do it better than our competition" - Corinne Le Goof, VP CNS Marketing, Sanofi Aventis. ... We need to understand customer value and do it better than our competition" - Corinne Le Goof, VP CNS Marketing, Sanofi
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Featured jobs
-
Associate Director
-
£75, 000-90, 000
-
Business Director
-
Competitive Salary Offered
- Principal Health Economist - North-West
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Business Development Director – Health Education
-
excellent commission
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
- Account Manager- Healthcare Advertising
-
Negotiable
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Account Director
-
Competitive Salary Offered
-
Systematic Reviewer - Oxford
-
Negotiable
-
Account Manager
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
- Circassia seeks shift to AIM after failing LSE criteria
- Beneluxa: the future of European market access?
- Fishawack acquires Blue Latitude Health
- FDA clears Sandoz and Pear’s Opioid Use Disorder app
- As May delays, industry warns again of ‘no-deal’ Brexit
- Clark Health Communications and Egg digital announce new collaboration
PMHub
Virgo Health
Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
